SWX:NOVNPharmaceuticals
Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong Multi‑Year Run?
If you are wondering whether Novartis is still reasonably priced after a strong run, this breakdown is designed to help you weigh what you are paying against what you are getting.
The share price recently closed at CHF 116.88, with returns of 0.3% over 7 days, 6.6% over 30 days, 7.7% year to date, 26.6% over 1 year, 74.2% over 3 years and 83.5% over 5 years.
These returns sit against a backdrop of continuing interest in large, diversified healthcare groups, as investors look for companies...